Johnson & Johnson (NYSE: JNJ) today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...
As India marks a decade of its Act East Policy, Odisha is a vital hub, with its grand shoreline, foundational ports, and its historic maritime ties across southeast Asia, to unlock opportunities and ...